Endothelial progenitor cells and plasma vascular endothelial growth factor and stromal cell-derived factor-1 during ranibizumab treatment for neovascular age-related macular degeneration. [electronic resource]
Producer: 20140214Description: 530-8 p. digitalISSN:- 1557-7732
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Biomarkers -- blood
- Cell Count
- Chemokine CXCL12 -- blood
- Choroidal Neovascularization -- blood
- Drug Administration Schedule
- Endothelial Cells -- drug effects
- Endothelium, Vascular -- drug effects
- Female
- Humans
- Intravitreal Injections
- Macular Degeneration -- blood
- Male
- Ranibizumab
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.